4//SEC Filing
THEUER CHARLES 4
Accession 0001193125-25-320992
CIK 0001650648other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:35 PM ET
Size
6.7 KB
Accession
0001193125-25-320992
Insider Transaction Report
Form 4
THEUER CHARLES
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-12$1.14/sh+9,333$10,640→ 41,684 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-12−9,333→ 0 totalExercise: $1.14Exp: 2026-03-09→ Common Stock (9,333 underlying)
Footnotes (1)
- [F1]Fully vested.
Documents
Issuer
4D Molecular Therapeutics, Inc.
CIK 0001650648
Entity typeother
Related Parties
1- filerCIK 0001631338
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:35 PM ET
- Size
- 6.7 KB